As inefficient apoptosis induction is a major cause of chemotherapy resistance33, we hypothesized that MLN4924 may thereby enhance the effectiveness of standard-of-care CRC chemotherapeutic agents in a p53-dependent manner. Here, TP53 is linked to colorectal carcinoma.